Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TLR4 | O00206 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12861148 | 0.87 | ALDH1A1 (0.36) | ALDH1A1MAPTL3MBTL1GAANPC1 | |
| SCHEMBL1004976 | 0.78 | ALDH1A1 (0.52) | ALDH1A1MAPTL3MBTL1GAATLR4 | |
| SCHEMBL2431325 | 0.76 | NPC1 (0.58) | ALDH1A1GAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7910636 | 0.75 | NPC1 (0.59) | ALDH1A1GAANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8393094 | 0.73 | TP53 (0.39) | ALDH1A1MAPTL3MBTL1GAA | |
| SCHEMBL9122284 | 0.71 | PTPN1 (0.39) | ALDH1A1MAPTGAANPC1RAB9A | |
| SCHEMBL12417561 | 0.70 | ALDH1A1 (0.39) | ALDH1A1MAPTGAANPC1RAB9A | |
| SCHEMBL11388147 | 0.69 | ALDH1A1 (0.37) | ALDH1A1MAPTL3MBTL1GAA | |
| SCHEMBL1401961 | 0.68 | ALDH1A1 (0.34) | ALDH1A1MAPTL3MBTL1GAA | |
| SCHEMBL8076491 | 0.68 | TP53 (0.47) | ALDH1A1MAPTL3MBTL1GAAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2319621-A2 | Base stable ionic liquids | The Queen's University of Belfast (GB) | 2011-05-11 | — | — | EP | disclosed |
| EP-2286915-A2 | IONIC LIQUIDS WITH A CATION COMPRISING A BASIC MOIETY | The Queen's University of Belfast (GB) | 2011-02-23 | — | — | EP | disclosed |
| US-20090270248-A1 | Basic ionic liquids | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-10-29 | — | — | US | disclosed |
| US-20090270248-A1 | Basic ionic liquids | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-10-29 | — | — | US | disclosed |
| US-20090216015-A1 | Base Stable Ionic Liquids | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-08-27 | — | — | US | disclosed |
| US-20090216015-A1 | Base Stable Ionic Liquids | THE QUEEN'S UNIVERSITY OF BELFAST (GB) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090216015-A1 | Base Stable Ionic Liquids | BRAF, TIAL1, HPRT1 | ALDH1A1 2477/4885MAPT 1496/4885L3MBTL1 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.